Human Parvovirus 4 Infection, Cameroon
- Myriam Lavoie
- Colin P. Sharp
- Jacques Pépin
- Christopher Pennington
- Yacouba Foupouapouognigni
- Oliver G. Pybus
- Richard Njouom
- Peter Simmonds
Publication date
April 2012
DOI Publisher
Centers for Disease Control and Prevention (CDC) Journal
Emerging Infectious DiseasesAbstract
In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C virus seropositivity. Findings suggest parenteral acquisition of some PARV4 infections
Add to ORKG